Dhansa Labs Ltd (DHANSA) — shareholding pattern, promoter holding, financials and share price
About Dhansa Labs Ltd (DHANSA)
Dhansa Labs Ltd operates in the Other Industrial Products industry, within the Capital Goods sector. It trades on the NSE as DHANSA and on the BSE under scrip code 92828. Its ISIN is INE0M3I01029.
Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products. [1]
Ambey Laboratories Ltd operates in the agrochemical sector, manufacturing products for crop protection, primarily 2,4-D base chemicals, which are crucial for sustainable farming.
The company maintains high environmental, health, and safety standards and has achieved ISO 9001:2015 certification, indicating a commitment to quality and compliance.
Listed peers in Other Industrial Products: Delta Manufacturing Ltd, Brace Port Logistics Ltd, Deccan Transcon Leasing Ltd, Pranik Logistics Ltd, Storage Technologies & Automation Ltd, Rexpro Enterprises Ltd.
Valuation & Returns
10 Jul 2026At ₹23 a share on 10 Jul 2026, Dhansa Labs Ltd (DHANSA) was valued at a price-to-earnings ratio of 10.41x against an industry P/E of 37x and a price-to-book of 0.58x on a book value of ₹39.62 per share. Solomo computes return on equity of 5.59% and return on capital employed of 7.23% from filed results.
- P/E
- 10.41x
- Industry P/E
- 37x
- P/B
- 0.58x
- EPS (TTM)
- ₹2.21
- Book value / share
- ₹39.62
- ROE
- 5.59%
- ROCE
- 7.23%
- ROA
- 3.66%
- Debt / equity
- 0.4x
- Dividend yield
- 0%
- EBITDA margin
- 8.63%
- 52-week range
- ₹16.2 – ₹48.3
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Dhansa Labs Ltd (DHANSA) reported revenue of ₹142 crore, net profit of ₹6 crore and earnings per share of ₹2.21. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹40.54 crore and net profit ₹2 crore (consolidated).
| Metric | Mar 2026 |
|---|---|
| Revenue (₹ cr) | 142 |
| Net profit (₹ cr) | 6 |
| EPS (₹) | 2.21 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 15.77% | 8.96% |
| Profit growth | 10.19% | -38.08% |
| Stock price CAGR | - | -43% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 65.05% of Dhansa Labs Ltd (DHANSA) (down 5.1 pp QoQ). Market capitalisation was ₹57 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2024.
Largest disclosed public shareholders in Jun 2026: Patel Charmi Nayanbhai 1.35%, Reema Pratit Patel 1.35%, Meena Nayan Patel 1.34%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 65.05% | - | - | - | - |
| Mar 2026 | 70.15% | - | - | - | - |
| Sep 2025 | 70.15% | - | - | - | - |
| Mar 2025 | 70.11% | - | - | - | - |
| Sep 2024 | 69.9% | - | - | - | - |